AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
RUA Life Sciences Delivers Positive Performance from ABISS French Subsidiary Following Acquisition
February 03, 2025 06:22 PM AEDT| By Team Kalkine MediaHighlights:,Revenue Growth:,ABISS achieved €2.3 million in revenue for the year to December 2024, marking a 7% increase over 2023.,Profit Turnaround:,The subsidiary recorded a profit before tax of €46k, a significant recovery from the previous year’s...
Alliance Pharma Reports Stable Revenues in 2024 Trading Update
January 31, 2025 06:51 PM AEDT| By Team Kalkine MediaHighlights,Total revenues for 2024 reached £180.3 million, marking a 1% YoY decline but a 1% increase at constant exchange rates (CER).,Consumer healthcare revenue dropped by 2% CER, while prescription medicine revenue saw an 8% CER rise.,The company...
CSL Limited (ASX:CSL) Analyzing 5-Year Earnings Growth Amidst Share Price Decline
January 31, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,CSL’s share price dropped 13% over five years despite steady earnings growth.,The company's earnings per share (EPS) increased by 5.2% annually during this period.,Revenue growth outpaced market expectations, rising 11% per year.,CSL Limit...
CVS Group Reports 6.6% Increase in Sales for H1 2025 Amid Market Challenges
January 30, 2025 06:40 PM AEDT| By Team Kalkine MediaHighlights,Sales Growth:,Group sales up 6.6%, totaling £341.8m for H1 2025.,Adjusted EBITDA:,Increased by 4.5% to £67.4m, with an EBITDA margin of 19.7%.,Expansion into Australia:,Investment focus shifting to Australia, with no new UK acquisitions du...
hVIVO Acquires Two Clinical Research Units in €10M Deal to Expand European Footprint
January 29, 2025 06:46 PM AEDT| By Team Kalkine MediaHighlights,hVIVO acquires two German clinical research units,from CRS for,€10 million,in cash.,Expands services to include Phase I and II trials,across multiple therapeutic areas.,Strengthens European presence,with,120-bed capacity,across two sites i...
ImmuPharma (LON:IMM) Trading Up 9.3%: Positive Movement in Specialty Biopharma
January 27, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,ImmuPharma's (IMM) share price surged by 9.3% on Saturday.,The company saw significant trading volume with a 60% increase from average daily shares.,ImmuPharma is known for developing peptide-based therapeutics targeting autoimmune disease...
Hikma Pharmaceuticals (LON:HIK) Hits New 52-Week High Amid Positive Market Sentiment
January 27, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Hikma Pharmaceuticals reaches a new 52-week high, signaling strong market performance.,Stock shows impressive growth with a significant increase in trading volume.,The company's solid fundamentals indicate a robust position in the pharmace...
hVIVO Secures £2.7m Laboratory Services Contract, Marking Largest Standalone Deal to Date
January 21, 2025 07:18 PM AEDT| By Team Kalkine MediaHighlight,Major Contract Win:,hLAB signs a £2.7m contract for a Phase 2 influenza drug trial, bringing the project's total value to £3.2m.,International Scope:,hLAB to support a multi-site Phase 2 study involving 5,000 subjects.,Expanded Laboratory C...
Creo Medical Group PLC (LON:CREO) Insider Purchase Reflects Confidence Amid Market Activity
January 21, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Christopher Paul Hancock acquired 4,712 shares of Creo Medical Group (CREO).,The stock opened lower on Tuesday, reflecting a slight market dip.,Creo Medical Group focuses on advancing electrosurgical medical devices in endoscopy.,Creo Medi...
ImmuPharma (LON:IMM) Sees 27.6% Surge – What’s Driving the Momentum?
January 20, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,ImmuPharma's (IMM) shares surged by 27.6% during recent trading.,Stock reached a high of GBX 3.60 before closing at GBX 3.35.,Market capitalization stands at £13.95 million, signaling increased investor attention.,ImmuPharma plc (LON:IMM),...
ImmuPharma (LON:IMM) Rises 27.6% Amid Renewed Market Interest
January 20, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,ImmuPharma shares climbed 27.6% during recent trading, reaching GBX 3.60 at their peak.,Trading volume declined 61% compared to the average daily activity, with 8,992,934 shares traded.,The company focuses on developing peptide-based thera...
ImmuPharma (LON:IMM) Climbs 27.6% Amid Renewed Focus on Therapeutic Innovations
January 20, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,ImmuPharma shares surged 27.6% during recent trading, reaching an intraday high of GBX 3.60.,Trading volume saw a 61% decline from the average, with 8,992,934 shares changing hands.,The company’s lead program, P140 (Lupuzor™), targets Lupu...
ImmuPharma (LON:IMM) Sees 27.6% Rise in Stock Price
January 20, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,ImmuPharma (IMM) stock price surged 27.6% on Saturday.,Trading volume reached 8,992,934 shares, marking a 61% decrease from the average.,The company specializes in peptide-based therapeutics for autoimmune diseases.,ImmuPharma plc (LON:IMM...
ImmuPharma (LON:IMM) Experiences Notable Stock Surge of 27.6%
January 20, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,ImmuPharma (IMM) shares surged by 27.6% during Saturday's trading session.,Stock peaked at GBX 3.60, closing at GBX 3.35, marking a significant increase.,Trading volume of 8,992,934 shares was notably lower than average daily volume.,ImmuP...
Futura Medical's Stock Movement and Healthcare Innovations
January 17, 2025 09:12 PM AEDT| By Team Kalkine MediaHeadlines,Futura Medical's Momentum Shifts Below Moving Average,Exploring Futura's Pharmaceutical Innovations,Understanding Futura's Strategic Product Portfolio,Futura Medical plc,,(LON:FUM),a prominent name in the pharmaceutical industry, has recent...
Avacta Therapeutics Announces Promising Tumor Shrinkage Data in Salivary Gland Cancer for AVA6000
January 16, 2025 06:27 PM AEDT| By Team Kalkine MediaHighlights,Encouraging Results in Salivary Gland Cancer:,New Phase 1a data shows meaningful tumor shrinkage in patients with salivary gland cancer (SGC), a rare and challenging disease with no standard metastatic therapy.,Advancing into Phase 1b Tria...
Genus Expects FY25 Half-Year Performance to Exceed Expectations
January 15, 2025 07:07 PM AEDT| By Team Kalkine MediaHighlights:,Adjusted Profit Before Tax Expected to Exceed £35 Million,Strong Performance Across ABS and PIC Divisions,Progress in PRRS1 Resistant Pig Programme Regulatory Approval,Genus (LSE:GNS), a global leader in animal genetics, expects to report...
Biotech Growth Trust: Insights into Recent Insider Activity and Strategic Focus
January 15, 2025 03:30 PM AEDT| By Team Kalkine MediaHeadlines,Nicola Shepherd, an insider at The Biotech Growth Trust PLC, made a notable share purchase.,The Biotech Growth Trust PLC focuses on investments in the biotechnology sector.,The company's financial metrics and performance have drawn attentio...
Gym Group Faces Key Market Challenges Amid Insider Confidence
January 15, 2025 06:29 AM AEDT| By Team Kalkine MediaHeadlines,The Gym Group's stock crosses below key moving averages.,Insider activity shows confidence in the company's performance.,Key financial metrics reflect the company's ongoing challenges.,The Gym Group,(LON:GYM),recently saw its stock drop bel...
Trellus Health Partners with Johnson & Johnson for Inflammatory Bowel Disease Pilot Program
January 14, 2025 06:54 PM AEDT| By Team Kalkine MediaHighlights:,Strategic Partnership,: Trellus Health will integrate its Trellus Elevate™ program into a Patient Support Program (PSP) for eligible patients prescribed a Johnson & Johnson therapy for IBD.,Financial Terms,: Trellus Health will receive an...
AI on the Rise: A Look at Top AI Companies and Their Stocks